Abstract
SUMMARYThis Cochrane review supports existing recommendations for risperidone and advances understanding of the use of valproate in patients with schizophrenia who are agitated or aggressive.DECLARATION OF INTERESTJ.C. conducted clinical trials of antipsychotics sponsored by Janssen Pharmaceuticals between 1978 and 1998 and met Dr Paul Janssen.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference28 articles.
1. How Paul Janssen's drugs saved the Chinese warriors;Andersen;Pharmacologist,2005
2. Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis
3. Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation);Ostinelli;Cochrane Database of Systematic Reviews,2018
4. Clinical observation of treatment with impulsive and aggressive behavior in patients with schizophrenia risperidone combined with valproate;Wang;Chinese Journal of Clinical Rational Drug Use,2013